Literature DB >> 34224317

Biomarkers for early detection of pancreatic cancer - miRNAs as a potential diagnostic and therapeutic tool?

Aleksandra Tarasiuk1, Tomasz Mackiewicz1, Ewa Małecka-Panas2, Jakub Fichna1.   

Abstract

Pancreatic ductal adenocarcinoma (PDAC) is one of the deadliest malignancies, with poor prognosis resulting mostly from late diagnosis. Surgery remains the most effective treatment and early detection significantly increases the overall survival. Biomarkers used for diagnosis and to monitor the response to treatment, such as carbohydrate antigen 19-9 (CA19-9) and carcinoembryonic antigen (CEA), are not adequate as early detection markers of PDAC, partly due to low sensitivity/specificity. Therefore, new biomarkers for PDAC are critically needed. This review aims at recent advancements in the identification and characterization of new biomarkers, microRNAs, which might prove useful in the early detection of PDAC.

Entities:  

Keywords:  Pancreatic ductal adenocarcinoma; biomarkers; early detection; miRNA

Mesh:

Substances:

Year:  2021        PMID: 34224317      PMCID: PMC8386725          DOI: 10.1080/15384047.2021.1941584

Source DB:  PubMed          Journal:  Cancer Biol Ther        ISSN: 1538-4047            Impact factor:   4.875


  52 in total

1.  Serum microRNA expression profile as a biomarker in the diagnosis and prognosis of pancreatic cancer.

Authors:  Rui Liu; Xi Chen; Yiqi Du; Weiyan Yao; Lin Shen; Cheng Wang; Zhibin Hu; Rui Zhuang; Guang Ning; Chunni Zhang; Yaozong Yuan; Zhaoshen Li; Ke Zen; Yi Ba; Chen-Yu Zhang
Journal:  Clin Chem       Date:  2011-12-22       Impact factor: 8.327

2.  Frequent detection of pancreatic lesions in asymptomatic high-risk individuals.

Authors:  Marcia Irene Canto; Ralph H Hruban; Elliot K Fishman; Ihab R Kamel; Richard Schulick; Zhe Zhang; Mark Topazian; Naoki Takahashi; Joel Fletcher; Gloria Petersen; Alison P Klein; Jennifer Axilbund; Constance Griffin; Sapna Syngal; John R Saltzman; Koenraad J Mortele; Jeffrey Lee; Eric Tamm; Raghunandan Vikram; Priya Bhosale; Daniel Margolis; James Farrell; Michael Goggins
Journal:  Gastroenterology       Date:  2012-01-12       Impact factor: 22.682

Review 3.  Key biological processes driving metastatic spread of pancreatic cancer as identified by multi-omics studies.

Authors:  T Y S Le Large; M F Bijlsma; G Kazemier; H W M van Laarhoven; E Giovannetti; C R Jimenez
Journal:  Semin Cancer Biol       Date:  2017-03-30       Impact factor: 15.707

Review 4.  Early Detection of Pancreatic Cancer: Opportunities and Challenges.

Authors:  Aatur D Singhi; Eugene J Koay; Suresh T Chari; Anirban Maitra
Journal:  Gastroenterology       Date:  2019-02-02       Impact factor: 22.682

5.  Exosomes derived from cancer stem cells of gemcitabine-resistant pancreatic cancer cells enhance drug resistance by delivering miR-210.

Authors:  Zhiyong Yang; Ning Zhao; Jing Cui; Heshui Wu; Jiongxin Xiong; Tao Peng
Journal:  Cell Oncol (Dordr)       Date:  2019-11-12       Impact factor: 6.730

Review 6.  New Treatment Strategies for Metastatic Pancreatic Ductal Adenocarcinoma.

Authors:  Ritu Raj Singh; Eileen M O'Reilly
Journal:  Drugs       Date:  2020-05       Impact factor: 9.546

7.  Selection of reference genes is critical for miRNA expression analysis in human cardiac tissue. A focus on atrial fibrillation.

Authors:  Michela Masè; Margherita Grasso; Laura Avogaro; Elvira D'Amato; Francesco Tessarolo; Angelo Graffigna; Michela Alessandra Denti; Flavia Ravelli
Journal:  Sci Rep       Date:  2017-01-24       Impact factor: 4.379

8.  Diagnostic and therapeutic recommendations in pancreatic ductal adenocarcinoma. Recommendations of the Working Group of the Polish Pancreatic Club.

Authors:  Katarzyna Winter; Renata Talar-Wojnarowska; Andrzej Dąbrowski; Małgorzata Degowska; Marek Durlik; Anita Gąsiorowska; Stanisław Głuszek; Grażyna Jurkowska; Aleksandra Kaczka; Paweł Lampe; Tomasz Marek; Anna Nasierowska-Guttmejer; Ewa Nowakowska-Duława; Grażyna Rydzewska; Janusz Strzelczyk; Zbigniew Śledziński; Ewa Małecka-Panas
Journal:  Prz Gastroenterol       Date:  2019-03-12

9.  Inflammation, Biomarkers and Immuno-Oncology Pathways in Pancreatic Cancer.

Authors:  Belinda Lee; Peter Gibbs
Journal:  J Pers Med       Date:  2019-04-26

10.  Downregulation of miR-486-5p Enhances the Anti-Tumor Effect of 5-Fluorouracil on Pancreatic Cancer Cells.

Authors:  Wei Wang; Bowei Liu; Suofeng Sun; Ling Lan; Yu Chen; Shuangyin Han; Xiuling Li; Zhaoshen Li
Journal:  Onco Targets Ther       Date:  2020-02-24       Impact factor: 4.147

View more
  1 in total

1.  microRNA-569 inhibits tumor metastasis in pancreatic cancer by directly targeting NUSAP1.

Authors:  Xiaohui Guo; Yatian Li; Xiaofang Che; Kezuo Hou; Xiujuan Qu; Ce Li
Journal:  Aging (Albany NY)       Date:  2022-04-28       Impact factor: 5.682

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.